Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Return on Assets (2020 - 2025)

Goldenwell Biotech filings provide 6 years of Return on Assets readings, the most recent being 0.0% for Q3 2025.

  • On a quarterly basis, Return on Assets rose 1.0% to 0.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0%, a 1.0% increase, with the full-year FY2024 number at 0.01%, changed 0.0% from a year prior.
  • Return on Assets hit 0.0% in Q3 2025 for Goldenwell Biotech, up from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2025 to a low of 0.05% in Q3 2023.
  • Median Return on Assets over the past 5 years was 0.0% (2022), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Assets: decreased -5bps in 2023 and later rose 5bps in 2024.
  • Goldenwell Biotech's Return on Assets stood at 0.0% in 2021, then plummeted by -1433bps to 0.04% in 2022, then surged by 85bps to 0.01% in 2023, then skyrocketed by 68bps to 0.0% in 2024, then surged by 148bps to 0.0% in 2025.
  • The last three reported values for Return on Assets were 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025) per Business Quant data.